FA
DPLO

Friess Associates’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Friess Associates’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-193,249
Closed -$5.55M – 190
2015
Q3 		$5.55M Hold
193,249
– – 0.52% 69
2015
Q2 		$8.65M Buy
193,249
+41,515
+27% +$1.56M 0.72% 61
2015
Q1 		$5.25M Buy
151,734
+5,900
+4% +$161K 0.42% 75
2014
Q4 		$3.99M Buy
+145,834
New +$3.54M 0.32% 78

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Friess Associates's DPLO Position: Q4 2015 in Review

Friess Associates sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2015, closing a stake of 193,249 shares — an estimated $5.55M sold.

Friess Associates first reported a position in DPLO in Q4 2014 and held it in 4 quarters. The position peaked at $8.65M in Q2 2015. 151 funds tracked by Wall St. Rank hold DPLO as of Q4 2015.

  • Friess Associates reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2015 after selling out during the quarter.
  • Friess Associates sold 193,249 DIPLOMAT PHARMACY, INC. shares in Q4 2015, an estimated $5.55M.
  • Friess Associates first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 4 quarters.
  • Friess Associates's DIPLOMAT PHARMACY, INC. position peaked at $8.65M in Q2 2015.
  • 151 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2015.

Based on Friess Associates's 13F filing for Q4 2015, filed 12 Feb 2016.